Effect of thrombomodulin gene polymorphisms on venous thromboembolism: An analysis of evidence involving 6,629 patients

Abstract

Backgroud

The association between thrombomodulin gene (THBD) c.1418 C>T polymorphisms and the risk of venous thromboembolism (VTE) is controversial. The purpose of this meta-analysis was to evaluate THBD c.1418 C>T polymorphisms and the risk of VTE.

Methods

Computer searches were performed on the CNKI, Wanfang database, VIP database, PubMed, Embase, Web of Science, and Cochrane Library databases. The retrieval time limit was from the establishment of the database to June 2022. Case-control studies and cohort studies of THBD c.1418 C>T polymorphisms associated with VTE were included. The literature was screened according to inclusion and exclusion criteria, data extraction and literature quality evaluation. Meta-analysis was performed using STATA 14.0 software.

Results

A total of 12 literature were included, including 2980 cases in the case group and 3649 cases in the control group. The meta-analysis results showed no significant association of the THBD c.1418 C> T polymorphisms with the occurrence of VTE (T vs C: OR = 1.17, 95%CI = 0.93–1.48; TT vs CT+CC: OR = 1.00, 95%CI = 0.75–1.33; TT+CT vs CC: OR = 1.22, 95%CI = 0.94–1.59). Subgroup analyses revealed an increased risk of VTE in Asian populations due to THBD c.1418 C>T polymorphisms (T vs C: OR = 1.48, 95%CI = 1.06–2.07; TT vs CT+CC: OR = 1.80, 95%CI = 1.13–2.85; TT+CT vs CC: OR = 1.58, 95%CI = 1.07–2.32). THBD c.1418 C>T polymorphisms increased the risk of DVT (T vs C: OR = 1.51, 95%CI = 1.24–1.85; TT vs CT+CC: OR = 1.85, 95%CI = 1.10–3.12; TT+CT vs CC: OR = 1.64, 95%CI = 1.28–2.11). THBD c.1418 C>T polymorphisms reduced the risk of VTE in non-Asian populations (TT vs CT+CC: OR = 0.66, 95%CI = 0.45–0.98).

Conclusion

THBD c.1418 C>T polymorphisms is associated with VTE in Asian population, which may be a factor in the occurrence of VTE in Asian population. THBD c.1418 C>T polymorphisms increases the risk of DVT. Given the limitations of this meta-analysis, the conclusions require being further supported by large-scale and high-quality studies.

Keywords

Thrombomodulin venous thromboembolism meta-analysis polymorphisms

Get full access to this article

View all access options for this article.

References

Zhang

Jin

, et al. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism – a meta-analysis and systematic review. VASA 2020; 49(2): 141–146.

Abufarhaneh

Pandya

Alkhaja

, et al. Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: a systematic review and meta-analysis. Thromb Res 2022; 213: 47–56.

Ageno

Squizzato

Garcia

, et al. Epidemiology and risk factors of venous thromboembolism. Semin Thromb Hemost 2006; 32(7): 651–658.

Xiao-Ying

Fan

Cheng

, et al. Incidence and prevention of venous thromboembolism in acutely ill hospitalized elderly Chinese. Chin Medical J 2011; 124(3): 335–400.

Konstantinides

Meyer

Becattini

, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020; 41(4): 543–603.

Heit

Spencer

White

. The epidemiology of venous thromboembolism. J Thromb Thrombolysis 2016; 41(1): 3–14.

Zhang

Gao

Zhang

, et al. Association between MTHFR C677T polymorphism and venous thromboembolism risk in the Chinese population: a meta-analysis of 24 case-controlled studies. Angiology 2015; 66(5): 422–432.

Cai

Yang

Chen

, et al. Circulating ‘lncRNA OTTHUMT00000387022’ from monocytes as a novel biomarker for coronary artery disease. Cardiovasc Res 2016; 112(3): 714–724.

Niu

Xie

. The Role of Thrombomodulin in Diseases. Chin J Biochem Mol Biol 2021; 37(08): 998–1004.

10.

Osada

Maruyama

Kokame

, et al. A novel homozygous variant of the thrombomodulin gene causes a hereditary bleeding disorder. Blood Advances 2021; 5(19): 3830–3838.

11.

Abeyama

Stern

Ito

, et al. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J Clin Invest 2005; 115(5): 1267–1274.

12.

Van

Collen

Conway

. Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. Arteriosclerosis Thromb Vasc Biol 2004; 24(8): 1374–1383.

13.

Chesebro

Rahn

Carles

, et al. Increase in activated protein C mediates acute traumatic coagulopathy in mice. Shock (Augusta, Ga) 2009; 32(6): 659–665.

14.

Christiaans

Wagener

Esmon

, et al. Protein C and acute inflammation: a clinical and biological perspective. Am J Physiol Lung Cell Mol Physiol 2013; 305(7): L455–L466.

15.

Mosnier

Meijers

JCM

Bouma

. Regulation of Fibrinolysis in Plasma by TAFI and Protein C Is Dependent on the Concentration of Thrombomodulin. Thromb Haemost 2001; 85(1): 5–11.

16.

Rafiq

Liaquat

Saeed

, et al. Gene expression of thrombomodulin, TNF-α and NF-KB in coronary artery disease patients of Pakistan. Mol Biol Rep 2020; 47(10): 7575–7582.

17.

Martos

Oto

Fernández-Pardo

, et al. Increase of Neutrophil Activation Markers in Venous Thrombosis-Contribution of Circulating Activated Protein C. Int J Mol Sci 2020; 21(16): 5651.

18.

Lobato

White

Mathew

, et al. Thrombomodulin gene variants are associated with increased mortality after coronary artery bypass surgery in replicated analyses. Circulation 2011; 124(11 Suppl): S143–S148.

19.

Ringwald

Berger

Adler

, et al. Genetic polymorphisms in venous thrombosis and pulmonary embolism after total hip arthroplasty: a pilot study. Clin Orthop Relat Res 2009; 467(6): 1507–1515.

20.

Engbersen

Franken

Boers

, et al. Thermolabile 5, 10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Human Genetics 1995; 56(1): 142–150.

21.

Bertina

Koeleman

Koster

, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369(6475): 64–67.

22.

Barcellona

Fenu

Cauli

, et al. Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis. Thromb Haemostasis 2003; 90(6): 1061–1064.

23.

Amaral

Miranda-Vilela

Lordelo

, et al. Interactions among Methylenetetrahydrofolate Reductase (MTHFR) and cystathionine β-synthase (CBS) polymorphisms - a cross-sectional study: multiple heterozygosis as a risk factor for higher homocysteine levels and vaso-occlusive episodes. Genet Mol Res: GMR 2017; 16(1): 1–19.

24.

Navarro

Medina

Bonet

, et al. Association of the thrombomodulin gene c.1418C>T polymorphism with thrombomodulin levels and with venous thrombosis risk. Arterioscler Thromb Vas Biol 2013; 33(6): 1435–1440.

25.

Stang

. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25(9): 603–605.

26.

Wang

Chu

Zhang

, et al. Risk assessment of thrombomodulin gene polymorphism and pulmonary embolism. Chin J Crit Care Med: Electronic Edition 2021; 14(4): 269–274.

27.

Jiang

Niu

Feng

, et al. Correlation between the polymorphism of coagulation-related genes and lower extremity deep venous thrombosis. J Forensic Med 2021; 37(2): 145–150, 157.

28.

Zhang

Xia

Jiang

, et al. Association between Thrombomodulin (THBD) gene polymorphism and pulmonary thromboembolism in a Chinese population. Int J Clin Exp Med 2017; 10(4): 7123–7128.

29.

Zhang

Gong

Zhang

, et al. The associations between THBD c.1418C>T polymorphism and lower extremity deep vein thrombosis or endothelial progenitor cell. Int Angiol: A J Int Union Angiol 2021; 40(5): 381–387.

30.

Tang

Wang

, et al. Common genetic risk factors for venous thrombosis in the Chinese population. Am J Hum Genet 2013; 92(2): 177–187.

31.

Jiang

Jiao

Ding

, et al. Association between genetic polymorphisms and deep vein thrombosis in a Chinese population. Thromb Res 2015; 136(3): 687–689.

32.

Heit

Petterson

Owen

, et al. Thrombomodulin gene polymorphisms or haplotypes as potential risk factors for venous thromboembolism: a population-based case-control study. J Thromb Haemost 2005; 3(4): 710–711.

33.

Flem

Mennen

Aubry

, et al. Thrombomodulin Promoter Mutations, Venous Thrombosis, and Varicose Veins. Arterioscler Thromb Vasc Biol 2001; 21(3): 445–451.

34.

Fan

. The Correlation Research between the Polymorphisms of Blood Coagulation Factor V Leiden, Prothrombin G20210A and Thrombomodulin Gene c.1418C>T and the Clinical Biochemical Indexes and the Lower Extremity Deep Venous Thrombosis. Shanxi: Shanxi Medical University, 2016.

35.

Faioni

Franchi

Castaman

, et al. Mutations in the thrombomodulin gene are rare in patients with severe thrombophilia. Br J Haematol 2015; 118(2): 595–599.

36.

Aleksic

Folsom

Cushman

, et al. Prospective study of the A455V polymorphism in the thrombomodulin gene, plasma thrombomodulin, and incidence of venous thromboembolism: the LITE Study. J Thromb Haemost 2003; 1(1): 88–94.

37.

Weiler-Guettler

Christie

Beeler

, et al. A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J Clin Invest 1998; 101(9): 1983–1991.

38.

Weiler

Isermann

. Thrombomodulin. J Thromb Haemost: JTH 2003; 1(7): 1515–1524.

39.

Cheng

Sun

Liu

, et al. Identification of thrombomodulin as a dynamic monitoring biomarker for deep venous thrombosis evolution. Exp Ther Med 2020; 21(2): 142.

40.

Wang

Cao

, et al. Diagnostic value of thrombomodulin combined with D-dimer in lower extremity deep venous thrombosis after trauma. J Vasc Endovascular Surg 2022; 3: 345–348.

41.

Tahir

Majid

Bin Arif

, et al. Cerebral Infarction Followed by Myocardial Infarction in a Young Adult with Protein C and S Deficiency. Cureus 2020; 12(1): e6665.

42.

Welsh

Hoofnagle

Bamezai

, et al. Hemodynamic regulation of perivalvular endothelial gene expression prevents deep venous thrombosis. J Clin Invest 2019; 129(12): 5489–5500.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.08 MB